NEW PERSPECTIVE
Year : 2020 | Volume
: 10 | Issue : 2 | Page : 128--130
Chloroquine: Can it be a Novel Drug for COVID-19
Dinesh Kumar Badyal1, Rajiv Mahajan2
1 Department of Pharmacology; Department of Medical Education, CMCL-FAIMER Regional Institute, Christian Medical College, Ludhiana, Punjab, India
2 Department of Pharmacology, Adesh Institute of Medical Sciences and Research, Bathinda, Punjab, India
Correspondence Address:
Dinesh Kumar Badyal
Department of Pharmacology, CMCL-FAIMER, Christian Medical College, Ludhiana - 141 008, Punjab
India
Coronavirus disease 2019 (COVID-19) has been declared a pandemic by the World Health Organization. The United States Food and Drug Administration has not approved any drug or vaccine for the treatment of COVID-19; however, reports have emerged from different parts of the world about the potential therapeutic benefits of existing drugs. Chloroquine and phosphate hydroxychloroquine are the drugs currently in the limelight, and recently, the National Task Force for COVID-19 constituted by the Indian Council of Medical Research has recommended the use of antimalarial drug hydroxychloroquine for prophylaxis of severe acute respiratory syndrome-coronavirus 2 infection in selected high-risk individuals. This short write-up explores the potential efficacy and established safety of chloroquine in COVID-19.
How to cite this article:
Badyal DK, Mahajan R. Chloroquine: Can it be a Novel Drug for COVID-19.Int J App Basic Med Res 2020;10:128-130
|
How to cite this URL:
Badyal DK, Mahajan R. Chloroquine: Can it be a Novel Drug for COVID-19. Int J App Basic Med Res [serial online] 2020 [cited 2022 Jan 27 ];10:128-130
Available from: https://www.ijabmr.org/article.asp?issn=2229-516X;year=2020;volume=10;issue=2;spage=128;epage=130;aulast=Badyal;type=0 |
|
|
|
